Technical Analysis for ADRO - Aduro Biotech, Inc.

Grade Last Price % Change Price Change
grade F 2.88 2.86% 0.08
ADRO closed up 2.86 percent on Thursday, January 17, 2019, on 46 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical ADRO trend table...

Date Alert Name Type % Chg
Jan 17 20 DMA Support Bullish 0.00%
Jan 17 Outside Day Range Expansion 0.00%
Jan 16 20 DMA Support Bullish 2.86%
Jan 16 NR7 Range Contraction 2.86%
Jan 15 20 DMA Support Bullish 1.05%
Jan 14 180 Bearish Setup Bearish Swing Setup 1.77%
Jan 14 NR7 Range Contraction 1.77%
Jan 14 Inside Day Range Contraction 1.77%
Jan 10 20 DMA Support Bullish 0.70%
Jan 8 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.36%

Older signals for ADRO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aduro BioTech, Inc., a clinical-stage immuno-oncology company, focuses on the development of technology platforms designed to stimulate robust and durable immune responses against cancer. Its lead product candidate is CRS-207, which is in a Phase IIb clinical trial for the treatment of metastatic pancreatic cancer and unresectable malignant pleural mesothelioma. The company's cyclic dinucleotides product candidates are synthetic small molecule immune modulators that target and activate Stimulator of Interferon Genes receptor. Aduro BioTech, Inc. has collaboration agreement with Janssen Biotech, Inc. to develop drugs for the treatment of prostate and lung cancers. The company was formerly known as Oncologic, Inc. and changed its name to Aduro BioTech, Inc. in June 2008. Aduro BioTech, Inc. was founded in 2000 and is based in Berkeley, California.
Is ADRO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.925
52 Week Low 2.34
Average Volume 1,135,440
200-Day Moving Average 5.8207
50-Day Moving Average 2.9478
20-Day Moving Average 2.793
10-Day Moving Average 2.893
Average True Range 0.2637
ADX 16.7
+DI 19.0996
-DI 17.0235
Chandelier Exit (Long, 3 ATRs ) 2.4989
Chandelier Exit (Short, 3 ATRs ) 3.1311
Upper Bollinger Band 3.1166
Lower Bollinger Band 2.4694
Percent B (%b) 0.63
BandWidth 23.172216
MACD Line -0.0319
MACD Signal Line -0.0681
MACD Histogram 0.0362
Fundamentals Value
Market Cap 214.88 Million
Num Shares 74.6 Million
EPS -1.56
Price-to-Earnings (P/E) Ratio -1.85
Price-to-Sales 35.46
Price-to-Book 2.36
PEG Ratio 0.05
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.24
Resistance 3 (R3) 3.22 3.08 3.18
Resistance 2 (R2) 3.08 2.99 3.09 3.16
Resistance 1 (R1) 2.98 2.93 3.03 3.00 3.14
Pivot Point 2.84 2.84 2.87 2.85 2.84
Support 1 (S1) 2.74 2.75 2.79 2.76 2.62
Support 2 (S2) 2.60 2.69 2.61 2.60
Support 3 (S3) 2.50 2.60 2.58
Support 4 (S4) 2.52